Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
December 16th, 2025
Clinuvel Pharmaceuticals to File ACTH Generic for Approval in 2026 for Billion Dollar Market
Read More
December 16th, 2025
Clever Culture Systems - Positioned for Strong Growth and Profitability
Read More
December 16th, 2025
Syntara's Clever Phase Ib Skin Scarring Study in 2026 to Address 'Enormous' Market Opportunity
Read More
December 16th, 2025
Imugene Gets Clear Direction from FDA to Move into Pivotal Study
Read More
December 16th, 2025
Actinogen Medical - Good Rational for Positive Trial Outcome in 2026
Read More
November 21st, 2025
Chimeric Therapeutics - Stable Disease in Cohort 2
Read More
November 21st, 2025
Imugene Prioritises Azer-Cel Program; Reduces Internal Drug Development
Read More
October 28th, 2025
Aroa Biosurgery Delivers 4th Consecutive Positive Cashflow Quarter
Read More
October 28th, 2025
Second Best Quarter of Sales for Cogstate
Read More
October 28th, 2025
Robust Results for Blinklab Paves Way for Registrational Autism Study
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
